Pagari Life Science Corp.
BETHALTA, IL · Founded 2022 · CIK 0001993125 · Biotech · Private
Advanced anti-herpetic and wound-healing pharmaceutical drugs
pagarilifescience.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $678K
- 4 Form D · May 2026
- 5 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $275,000 | |
| Private capital raised | Form D · SEC | $55,500 | |
| Private capital raised | Form D · SEC | $97,494 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1176 | Cessation Therapeutics, Inc. | — | $6.8M |
| 1177 | Dnalite Therapeutics, Inc. | — | $5.6M |
| 1178 | Xenon Pharmaceuticals | — | — |
| 1179 | Pagari Life Science Corp. | — | $678K |
| 1180 | PRIMAL THERAPIES, INC. | — | $677K |
| 1181 | Grace Bio-Labs, Inc. | — | — |
| 1182 | NEUREXIS THERAPEUTICS, INC. | — | $605K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David FeldkerDirector · Executive Officer
- Stephen PeipertDirector · Executive Officer
- Stephen PiepertDirector
- Alan WickenhauserDirector
- James WickenhauserExecutive Officer
- Marni ZenkewiczExecutive Officer
Patents
- Compositions For Treating Genital Herpes And Methods Of Their Useapplication
- Treatment Of Herpes Zoster With Topical Tetracainegranted
- Treatment Of Herpes Zoster With Topical Tetracaineapplication
- Compositions For Treating Genital Herpes And Methods Of Their Useapplication
- Compositions For Treating Genital Herpes And Methods Of Their Useapplication
- Treatment Of Herpes Zoster With Topical Tetracaineapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.